EV/EBITDA:
44.99+0.58(+1.31%)Summary
- As of today, SUPN EV/EBITDA is 44.99, with a rise of +0.58 (+1.31%) during the most recent trading session on November 21, 2025.
- Over the past year, SUPN EV/EBITDA has increased by +34.65 (+335.11%).
- SUPN EV/EBITDA is now -22.11% below its all-time high of 57.76.
Performance
SUPN EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SUPN EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | +1.3% | +1.3% | +1.2% |
| 1M1 Month | - | -10.8% | -10.6% |
| 3M3 Months | +244.8% | +21.7% | +4.6% |
| 6M6 Months | +399.9% | +69.1% | +38.9% |
| YTDYTD | +333.4% | +47.8% | +25.3% |
| 1Y1 Year | +335.1% | +46.3% | +26.5% |
| 5Y5 Years | +652.3% | +100.6% | +118.1% |
SUPN EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | 57.76 | -22.1% | 44.03 | +2.2% |
| 3M | 3-Month | 57.76 | -22.1% | 13.05 | +244.8% |
| 6M | 6-Month | 57.76 | -22.1% | 8.47 | +431.2% |
| 1Y | 1-Year | 57.76 | -22.1% | 8.16 | +451.4% |
| 3Y | 3-Year | 57.76 | -22.1% | 8.16 | +451.4% |
| 5Y | 5-Year | 57.76 | -22.1% | 5.95 | +656.1% |
| All-Time | All-Time | 57.76 | -22.1% | -13.01 | +445.8% |
SUPN EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 44.99(+333.4%) |
| 2024 | 10.38(-25.6%) |
| 2023 | 13.95(-4.3%) |
| 2022 | 14.57(+18.8%) |
| 2021 | 12.26(+89.2%) |
| 2020 | 6.48(-63.9%) |
| Date | Value |
|---|---|
| 2017 | 17.94(-15.8%) |
| 2016 | 21.31(-29.5%) |
| 2015 | 30.21(+118.9%) |
| 2014 | 13.80(+378.8%) |
| 2013 | -4.95(-1.2%) |
| 2012 | -4.89 |
FAQ
- What is Supernus Pharmaceuticals, Inc. EV/EBITDA?
- What is the all-time high EV/EBITDA for Supernus Pharmaceuticals, Inc.?
- What is SUPN EV/EBITDA year-to-date change?
- What is Supernus Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
What is Supernus Pharmaceuticals, Inc. EV/EBITDA?
The current EV/EBITDA of SUPN is 44.99
What is the all-time high EV/EBITDA for Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. all-time high EV/EBITDA is 57.76
What is SUPN EV/EBITDA year-to-date change?
Supernus Pharmaceuticals, Inc. EV/EBITDA has changed by +34.61 (+333.43%) since the beginning of the year
What is Supernus Pharmaceuticals, Inc. EV/EBITDA year-on-year change?
Over the past year, SUPN EV/EBITDA has changed by +34.65 (+335.11%)